Lipella Pharmaceuticals Inc. (LIPO): Operating Income
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$5.08M
Year ended 2024-12-31
-$5.41M
Trailing 12 months to 2025-09-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | -$5.08M | n/m | 2025-03-28, From 2024-01-01 |
| 2023-12-31 | -$4.75M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$2.59M | n/m | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | -$1.92M | n/a | 2023-03-31, From 2021-01-01 |